Bucillamine

This classification denotes an antioxidant with the molecular formula C7H13NO3S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) R80LRA5WTF, chemically known as l-cysteine, n-(2-mercapto-2-methyl-1-oxopropyl)- but more generally known as bucillamine, which bears US NIH Compound Identifier 2459. European Medicines Agency schedules Bucillamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05944MIG. The term BUCILLAMINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 40, No. 6, 1986, List 26). World Health Organization schedules bucillamine in its Anatomical Therapeutic Chemical (ATC) Classification. BUCILLAMINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule bucillamine under HS 29309016 and SITC 51549. As of Q4 2014, BUCILLAMINE remains US FDA's Preferred Term for this commodity. Bucillamine bears US NLM identifiers UMLS ID C0073917 and NCI Concept Code C83561. SMILES: SC(C(=O)NC(CS)C(=O)O)(C)C.